Last update 08 May 2025

Zoster vaccine recombinant, adjuvanted(GlaxoSmithKline Plc)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Genetically engineered subunit vaccine
Synonyms
HZ/su, PED-HZ/su, QS-21 containing herpes zoster vaccine
+ [18]
Target-
Action
stimulants
Mechanism
Immunostimulants
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Canada (13 Oct 2017),
RegulationOverseas New Drugs Urgently Needed in Clinical Settings (China)
Login to view timeline

Structure/Sequence

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Neuralgia, Postherpetic
Liechtenstein
21 Mar 2018
Neuralgia, Postherpetic
Iceland
21 Mar 2018
Neuralgia, Postherpetic
European Union
21 Mar 2018
Neuralgia, Postherpetic
Norway
21 Mar 2018
Herpes Zoster
Canada
13 Oct 2017
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Herpes ZosterNDA/BLA
China
03 Feb 2024
Hematologic NeoplasmsPreclinical
Hong Kong
01 Mar 2013
Hematologic NeoplasmsPreclinical
New Zealand
01 Mar 2013
Hematologic NeoplasmsPreclinical
United Kingdom
01 Mar 2013
Hematologic NeoplasmsPreclinical
Panama
01 Mar 2013
Hematologic NeoplasmsPreclinical
Russia
01 Mar 2013
Hematologic NeoplasmsPreclinical
Taiwan Province
01 Mar 2013
Hematologic NeoplasmsPreclinical
Sweden
01 Mar 2013
Hematologic NeoplasmsPreclinical
United States
01 Mar 2013
Hematologic NeoplasmsPreclinical
Belgium
01 Mar 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
530
lgkmxuiuew(qbhoomvsvb) = avudwnowcv ffhugdwrzb (rdmbghctsd, kibvuzmmkf - jqzqrstvfa)
-
01 Apr 2025
lgkmxuiuew(qbhoomvsvb) = qlqifxdjwx ffhugdwrzb (rdmbghctsd, ycecxcddot - djcwyupchc)
Phase 3
1,430
cgnduvzzln(nounlrgmcz) = aijmjcobxc tvmdaeqpbg (wafordjkyl, voicmltatx - efeozozkdi)
-
30 Mar 2025
Placebo
(Placebo Group)
cgnduvzzln(nounlrgmcz) = jtuhfsjitc tvmdaeqpbg (wafordjkyl, ojfkhjtdvm - nowqdzlhgf)
Phase 4
15
(UC Patients on Tofacitinib Monotherapy)
jwdolhbvpt(ttdsrqcekq) = kklnpclzhn xbzbuhifkt (wlgyaxyruy, xjwazyczls - dorijhjuvs)
-
21 Feb 2025
(UC Patients on Anti-TNF Monotherapy)
jwdolhbvpt(ttdsrqcekq) = nwdtdmwjvn xbzbuhifkt (wlgyaxyruy, zjkbagipej - urrwrlamvh)
Phase 4
6,138
(RZV Group)
lbhojhatwj(tvkqppswwc) = pzndurgdyb vewtymavbs (mhzsmqcjpa, iutjatuixt - dxhuhotbqv)
-
19 Sep 2024
Placebo
(Placebo Group)
lbhojhatwj(tvkqppswwc) = hhavsmlbtq vewtymavbs (mhzsmqcjpa, zihgraavhq - tfbsddnnbz)
Phase 2
38
(Younger Group)
vhlnmlgujs(xxolipghbo) = ovsaovyuwb jezyimmunt (smqzjmftry, trrnwqqnsk - lkxcjukoek)
-
30 Jul 2024
(Older Group)
vhlnmlgujs(xxolipghbo) = lssmmnylbp jezyimmunt (smqzjmftry, zgwvykaleu - mrkwazwske)
Pubmed
ManualManual
Not Applicable
-
hxpwftjyah(wdlmgcqbse) = qigylmytoc ihmwdpsqcw (rwsrdpptbl )
Positive
25 Jul 2024
Not Applicable
59,713
Adjuvanted Recombinant Zoster VaccineRZVuvanted Recombinant Zoster Vaccine
(RZV (2-dose))
iqszyqfzfm(bjjqfimhfq) = ryctqnckvk swbnqrgpwa (zrqarakubf )
Positive
05 Jun 2024
iqszyqfzfm(bjjqfimhfq) = sunyovqhmj swbnqrgpwa (zrqarakubf )
Phase 3
-
SHINGRIX (Recombinant Zoster Vaccine or RZV)
(mbdllyswgk) = zzyrqxczyj hhonibhgbb (umaebapdlj, 73.7 - 84.6)
Positive
17 Apr 2024
Phase 3
288
Placebo
ufymrwnmfq(awnjkxrzlq) = nfemikgkka cuumgkxyie (pchebnerqo, kbhqgvnfiw - rbcrdlvspy)
-
08 Apr 2024
Phase 3
68
hffxlsudaj(igrbxqugec) = xpvlggkpvu kkmnmiwpwo (ddhzlagkib, fgmzidqrog - fgbwaacyuy)
-
20 Dec 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free